Bluejay Diagnostics Inc. (BJDX)
NASDAQ: BJDX
· Real-Time Price · USD
2.04
0.13 (6.81%)
At close: May 01, 2025, 3:59 PM
1.92
-6.11%
Pre-market: May 02, 2025, 05:10 AM EDT
6.81% (1D)
| Bid | 1.92 |
| Market Cap | 3.06M |
| Revenue (ttm) | 108.04K |
| Net Income (ttm) | -7.72M |
| EPS (ttm) | -114.19 |
| PE Ratio (ttm) | -0.02 |
| Forward PE | -0.02 |
| Analyst | n/a |
| Ask | 2.02 |
| Volume | 3,572,621 |
| Avg. Volume (20D) | 1,181,808 |
| Open | 1.92 |
| Previous Close | 1.91 |
| Day's Range | 1.87 - 2.08 |
| 52-Week Range | 1.46 - 316.80 |
| Beta | 0.35 |
About BJDX
Bluejay Diagnostics, Inc., a diagnostic company, develops and markets patient products for triage, diagnosis, and monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony Fluorescence Immuno-analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge Library, which includes reag...
Industry Medical - Devices
Sector Healthcare
IPO Date Nov 10, 2021
Employees 7
Stock Exchange NASDAQ
Ticker Symbol BJDX
Website https://www.bluejaydx.com
4 months ago
+59.38%
Bluejay Diagnostics shares are trading higher afte...
Unlock content with
Pro Subscription
5 months ago
-28.85%
Bluejay Diagnostics shares are trading lower after the company announced a 1-for-50 reverse stock split.
